Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 155
9
Diseases
25
Unique genes
0.191
Avg. similarity score
Neural tube defects, folate-sensitive
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Neural tube defects, folate-sensitive
Homocystinuria with megaloblastic anemia
Hyperhomocysteinemia
Anencephaly
Aprosencephaly
methylcobalamin deficiency type cblE
methylcobalamin deficiency type cblG
Malnutrition
Advanced sleep phase syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Neural tube defects, folate-sensitive | 7 | 7 | 4 |
| Homocystinuria with megaloblastic anemia | 6 | 6 | 4 |
| Hyperhomocysteinemia | 5 | 5 | 13 |
| Anencephaly | 4 | 4 | 9 |
| Aprosencephaly | 4 | 4 | 4 |
| methylcobalamin deficiency type cblE | 4 | 4 | 1 |
| methylcobalamin deficiency type cblG | 4 | 4 | 1 |
| Malnutrition | 3 | 3 | 3 |
| Advanced sleep phase syndrome | 1 | 1 | 3 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MTRR | 6 / 9 | Anencephaly, Aprosencephaly, Homocystinuria with megaloblastic anemia, Hyperhomocysteinemia and 2 more |
| MTR | 5 / 9 | Homocystinuria with megaloblastic anemia, Hyperhomocysteinemia, Malnutrition, methylcobalamin deficiency type cblG and 1 more |
| MTHFR | 4 / 9 | Anencephaly, Hyperhomocysteinemia, Malnutrition, Neural tube defects, folate-sensitive |
| CBS | 2 / 9 | Hyperhomocysteinemia, Malnutrition |
| NUAK2 | 2 / 9 | Anencephaly, Aprosencephaly |
| PER3 | 2 / 9 | Advanced sleep phase syndrome, Homocystinuria with megaloblastic anemia |
| RPGRIP1L | 2 / 9 | Anencephaly, Aprosencephaly |
| TRIM36 | 2 / 9 | Anencephaly, Aprosencephaly |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| One carbon pool by folate | KEGG | 5 / 38 | 63.2× | 1.22e-8 | 1.04e-6 ✓ sig. |
| Folate transport and metabolism | KEGG | 4 / 31 | 62.0× | 4.42e-7 | 2.41e-5 ✓ sig. |
| Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE | Reactome | 2 / 2 | 480× | 4.16e-6 | 1.63e-4 ✓ sig. |
| Defective MTR causes methylmalonic aciduria and homocystinuria type cblG | Reactome | 2 / 2 | 480× | 4.16e-6 | 1.63e-4 ✓ sig. |
| Metabolism of folate and pterines | Reactome | 3 / 17 | 84.8× | 5.32e-6 | 1.99e-4 ✓ sig. |
| Cobalamin transport and metabolism | KEGG | 3 / 18 | 80.1× | 6.37e-6 | 2.29e-4 ✓ sig. |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | Reactome | 3 / 21 | 68.6× | 1.03e-5 | 3.45e-4 ✓ sig. |
| Antifolate resistance | KEGG | 3 / 30 | 48.0× | 3.12e-5 | 8.62e-4 ✓ sig. |
| Circadian rhythm | KEGG | 3 / 34 | 42.4× | 4.57e-5 | 1.19e-3 ✓ sig. |
| Sulfur amino acid metabolism | Reactome | 2 / 6 | 160× | 6.21e-5 | 1.52e-3 ✓ sig. |
| Cysteine and methionine metabolism | KEGG | 3 / 52 | 27.7× | 1.65e-4 | 3.35e-3 ✓ sig. |
| Legionellosis | KEGG | 3 / 56 | 25.7× | 2.05e-4 | 3.98e-3 ✓ sig. |
| Methylation | Reactome | 2 / 14 | 68.6× | 3.73e-4 | 6.34e-3 ✓ sig. |
| The NLRP3 inflammasome | Reactome | 2 / 15 | 64.1× | 4.30e-4 | 7.08e-3 ✓ sig. |
| Pertussis | KEGG | 3 / 78 | 18.5× | 5.47e-4 | 8.53e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| homocysteine metabolic process | GO:0050667 | 4 / 10 | 299× | 5.20e-10 | 1.25e-7 ✓ sig. |
| methionine biosynthetic process | GO:0009086 | 4 / 11 | 272× | 8.17e-10 | 1.87e-7 ✓ sig. |
| methionine metabolic process | GO:0006555 | 3 / 6 | 374× | 4.22e-8 | 5.86e-6 ✓ sig. |
| cobalamin metabolic process | GO:0009235 | 3 / 9 | 249× | 1.77e-7 | 1.95e-5 ✓ sig. |
| non-motile cilium assembly | GO:1905515 | 4 / 57 | 52.5× | 9.38e-7 | 7.89e-5 ✓ sig. |
| folic acid metabolic process | GO:0046655 | 3 / 15 | 149× | 9.52e-7 | 7.98e-5 ✓ sig. |
| neural tube closure | GO:0001843 | 4 / 85 | 35.2× | 4.69e-6 | 2.85e-4 ✓ sig. |
| amino acid biosynthetic process | GO:0008652 | 3 / 27 | 83.1× | 6.06e-6 | 3.50e-4 ✓ sig. |
| S-adenosylmethionine metabolic process | GO:0046500 | 2 / 4 | 374× | 1.03e-5 | 5.33e-4 ✓ sig. |
| homocysteine catabolic process | GO:0043418 | 2 / 4 | 374× | 1.03e-5 | 5.33e-4 ✓ sig. |
| serine family amino acid metabolic process | GO:0009069 | 2 / 4 | 374× | 1.03e-5 | 5.33e-4 ✓ sig. |
| transsulfuration | GO:0019346 | 2 / 5 | 299× | 1.71e-5 | 7.95e-4 ✓ sig. |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 3 / 38 | 59.0× | 1.73e-5 | 8.00e-4 ✓ sig. |
| positive regulation of inflammatory response | GO:0050729 | 4 / 122 | 24.5× | 1.97e-5 | 8.86e-4 ✓ sig. |
| response to folic acid | GO:0051593 | 2 / 8 | 187× | 4.79e-5 | 1.74e-3 ✓ sig. |